Benjamin Berkowitz is a partner and intellectual property lawyer in the Washington, D.C. office of Foley & Lardner LLP. He has experience counseling clients on legal and strategic issues related to intellectual property, drafting and prosecuting patent applications in the U.S. and abroad, and evaluating intellectual property for due diligence analyses and freedom to operate opinions. Dr. Berkowitz has prosecuted a variety of chemical, biochemical and mechanical patents, in a broad spectrum of technologies including: plant molecular biology, antibodies, chemical sensors, optical equipment, small molecules, polymers, and pharmaceuticals. He practices in the firm's Chemical, Biotechnology & Pharmaceutical and International Practices, as well as the Life Sciences Industry Team. In addition, he was chair of the firm's National Associates Committee.
Dr. Berkowitz also counsels companies on due diligence matters for business deals and securities offerings. He has served as lead IP counsel for companies in deals totaling over $1.2 billion and worked with numerous companies in securities offerings, including IPOs.
Dr. Berkowitz maintains a niche practice in helping companies receive IP protection on plant varieties, including plant breeders rights protection, plant patents, and PVPA protection.
Articles in the National Law Review database by Benjamin A. Berkowitz